<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230716058802N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-07-29</date_registration>
      <primary_sponsor>Khoram-Abad University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of two methods of  Laryngeal Mask Airway insertion,Classic method  and using a Laryngoscope.</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of two methods of LMA insertion,Classic method  and using a Laryngoscope.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-08-05</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>106</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/71413</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Based on consecutive non-probability sampling, based on the order of hospitalization, eligible patients are sampled. In this way, the classes are made based on the age groups and gender of the patient (four classes in total). Within each class, random permutation block method is used to assign to two groups. The random tool will also be a table of random numbers. Due to the nature of the anesthesia technique, it was not used in this research. The initial sample size was 44 people in each group using the variable of pain severity and based on the statistical formula, and finally, taking into account the probability of 20% dropout, the final sample size was 53 people in each group (106 in total).</study_design>
      <phase>N/A</phase>
      <hc_freetext>Comparison of two methods of LMA insertion,Classic method  and using a Laryngoscope..</hc_freetext>
      <i_freetext>Intervention 1: Control group: Placing the LMA mask in the classic way: In this method, the LMA mask is inserted into the patient's mouth by the doctor's index finger, and then it is sent to the patient's throat in the hypopharynx area in the form of a midline while in direct contact with the patient's mouth and tongue. so that the tip of the mask is in contact with the esophagus, until it finally reaches a real resistance. Intervention 2: Intervention group: placement of LMA using laryngoscope: in this method, first we extend the patient's head back, after opening the patient's mouth, we insert the laryngoscope from the right side of the patient's mouth and open the oral space and after accessing the vision Appropriately, we fix the LMA in its anatomical position in the hypopharynx area. In this method, the patient does not undergo a laryngoscopy and the laryngoscope is used only to open the oral space and have a better view.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data is potentially shareable after de-identifying individuals.

When:
6 months after the results are published

To whom:
University researchers

Conditions:
Scientific use

Where to obtain:
Lorestan University of Medical Sciences website

How to obtain:
Clear request of the applicant on the website of Lorestan University of Medical Sciences to access the data and then review the request by the research assistant within 2 weeks and then allow access to the data.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Aram Azizi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No36,Saba street,Keyo squre</address>
        <city>Khorramabad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6817744491</zip>
        <telephone>+98 66 3321 5410</telephone>
        <email>aram.azizi0212@yahoo.com</email>
        <affiliation>Khoram-Abad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Aram Azizi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No36, Saba street,Keyo square</address>
        <city>Khorramabad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6817744491</zip>
        <telephone>+98 66 3321 5410</telephone>
        <email>aram.azizi0212@yahoo.com</email>
        <affiliation>Khoram-Abad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Elective surgery patients in Khorramabad Ashayer Hospital ,in 1402,
Patients with ASA class 1 and 2.
Patients with minor surgery.
Patients aged 18 to 65 years
Informed patients with written consent</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients with head and face injuries and head and neck abnormalities
Patients who have contraindications for LMA placement: such as high risk of aspiration, not fasting, pregnancy
Patients with difficult Airway</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Control group: Placing the LMA mask in the classic way: In this method, the LMA mask is inserted into the patient's mouth by the doctor's index finger, and then it is sent to the patient's throat in the hypopharynx area in the form of a midline while in direct contact with the patient's mouth and tongue. so that the tip of the mask is in contact with the esophagus, until it finally reaches a real resistance.</i_keyword>
      <i_keyword>Intervention group: placement of LMA using laryngoscope: in this method, first we extend the patient's head back, after opening the patient's mouth, we insert the laryngoscope from the right side of the patient's mouth and open the oral space and after accessing the vision Appropriately, we fix the LMA in its anatomical position in the hypopharynx area. In this method, the patient does not undergo a laryngoscopy and the laryngoscope is used only to open the oral space and have a better view.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Number of attempts to successfully insert LMA. Timepoint: After LMA placement. Method of measurement: Observe.</prim_outcome>
      <prim_outcome>Duration of placement of LMA. Timepoint: After LMA placement. Method of measurement: Observe.</prim_outcome>
      <prim_outcome>Presence of blood on the LMA. Timepoint: After removing the LMA. Method of measurement: Observe.</prim_outcome>
      <prim_outcome>Presence of air in the stomach. Timepoint: After removing the LMA. Method of measurement: Abdominal examination.</prim_outcome>
      <prim_outcome>Severity of sore throat after surgery  based on the VAS criterion. Timepoint: After the surgery is completed and the patient becomes conscious. Method of measurement: interview.</prim_outcome>
      <prim_outcome>Tooth damage. Timepoint: After LMA placement. Method of measurement: Observe.</prim_outcome>
      <prim_outcome>Doctor's satisfaction rate. Timepoint: After LMA placement. Method of measurement: Interview.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Khoram-Abad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-07-11</approval_date>
        <contact_name>Ethic committee of Lorestan University of Medical Sciences</contact_name>
        <contact_address>Dorud Khorramabad highway,Kmalvand,Lorestan University of Medical Sciences Khorramabad Lorestan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
